Functional cross-talk of Ca2+-mobilizing endothelin receptors in C6 glioma cells

Physiological Research

Volumn 51, Issue 1, 2002, Pages 73-78

  Malik R ^b   Vlasicova K ^b   Šedo, Aleksi ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Calcium signaling; Cell differentiation; Endothelin; Glioma

Indexed keywords

BUCLADESINE; CALCIUM ION; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST; ENDOTHELIN RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; SARAFOTOXIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CARCINOGENESIS; CELL DIFFERENTIATION; CELL SUSPENSION; GLIOMA CELL; NONHUMAN; RAT;

ANIMALS; BRAIN NEOPLASMS; CALCIUM; CELL DIFFERENTIATION; ENDOTHELIN-1; ENDOTHELIN-3; FLUORESCENT DYES; FURA-2; GLIOMA; OLIGOPEPTIDES; PIPERIDINES; RATS; RECEPTOR CROSS-TALK; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VIPER VENOMS;

EID: 0036193946     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cyclic AMP-mediated induction of the glial fibrillary acidic protein is independent of protein kinase A activation in rat C 6 glioma
2. Differentiated rat glial cell strain in tissue culture
3. The endothelin subtype A receptor undergoes agonist- and antagonist-mediated internalization in the absence of signaling
4. Adaptation of C6 glioma cells to serum-free conditions leads to the expression of a mixed astrocyteoligodendrocyte phenotype and increased production of neurite-promoting activity
5. cAMP-dependent down-regulation of endothelin- 1 receptors on rat astrocytoma C6 cells
6. The astrocytic endothelin system: Toward solving a mystery focus on "distinct pharmacological properties of ET-1 and ET-3 on astroglial gap junctions and Ca(2+) signaling"
7. Endothelin B receptor-deficient rats as a subtraction model to study the cerebral endothelin system
8. Manipulation of intracellular calcium in NCB-20 cells
9. Molecular pharmacology and pathophysiological significance of endothelin
10. A endothelin receptors exhibit different sensitivities to BQ-123
11. Endothelin mechanisms in the central nervous system
12. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788
13. B specific ligands synergistically antagonize endothelin-1 I binding to an atypical endothelin receptor in primary rat astrocytes
14. Endothelin in brain: Receptors, mitogenesis, and biosynthesis in glial cells
15. Heterogeneity of cell surface endothelin receptors
16. Distinct subdomains of human endothelin receptors determine their selectivity to endothelin A-selective antagonist and endothelin B-selective agonists
17. Transient increase in intracellular concentration of adenosine 3′:5′-cyclic monophosphate results in morphological and biochemical differentiation of C6 glioma cells in culture
18. Endothelins and sarafotoxins: Receptor heterogeneity
19. 2+ sensitization in vascular smooth muscle
20. BQ-123 inhibits both endothelin 1 and endothelin 3 mediated C6 rat glioma cell proliferation suggesting an atypical endothelin receptor
21. Calcium-mediated endothelin signaling in C6 rat glioma cells
22. B receptor
23. Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypes
24. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
25. Does blockade of endotelin BI-receptor activation increase endothelin B2/endothelinA receptor-mediated constriction in the rabbit basilar artery?